Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea · Delayed Price · Currency is KRW 19,750
-1,400 (-6.62%)
At close: Jul 20, 2026
Aimed Bio Market Cap
Aimed Bio has a market cap or net worth of 1.28 trillion as of July 20, 2026.
Market Cap
1.28T
Enterprise Value
1.20T
Revenue
54.20B
Ranking
n/a
PE Ratio
276.79
Stock Price
19,750.00
ChartMarket Cap Chart
Since December 4, 2025, Aimed Bio's market cap has decreased from 2.82T to 1.28T, a decrease of -54.75%. That is a compound annual growth rate of -71.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.28T | -65.44% |
| Dec 30, 2025 | 3.70T | 30.91% |
| Dec 4, 2025 | 2.82T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Link | 1.12T |
| ROKIT Healthcare | 971.89B |
| Rznomics | 823.49B |
| Qurient | 657.14B |
| AprilBio | 561.93B |
| Inventage Lab | 412.92B |
| Curocell | 341.82B |
| IntoCell | 307.95B |